Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/NON-RI) Kazakhmys Plc

14th Jun 2013 09:39

RNS Number : 0694H
Societe Generale SA
14 June 2013
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

SOCIETE GENERALE SA

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Kazakhmys Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mr. Alexander Machkevitch, Mr. Alijan Ibragimov, Mr. Patokh Chodiev and the Kazakh Government

(d) Date position held/dealing undertaken:

13/06/2013

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES : Eurasian Natural Resources Corp Plc

 

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

20p ordinary share

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

328,676

0.06

175,359

0.04

(2) Derivatives (other than options):

1,236

0.00

0

0.00

(3) Options and agreements to purchase/sell:

17,809

0.00

17,809

0.00

TOTAL:

347,721

0.06

193,168

0.04

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

(GBP)

Ordinary share

Purchase

2,000

2.9630

Ordinary share

Purchase

862

2.9860

Ordinary share

Purchase

340

3.0150

Ordinary share

Purchase

785

2.8500

Ordinary share

Purchase

1,209

2.8520

Ordinary share

Purchase

540

2.8580

Ordinary share

Purchase

739

2.9900

Ordinary share

Purchase

1,746

2.9550

Ordinary share

Purchase

601

2.8600

Ordinary share

Purchase

2,108

2.8270

Ordinary share

Purchase

145

2.9820

Ordinary share

Purchase

150

2.9840

Ordinary share

Purchase

2,212

2.8930

Ordinary share

Purchase

2,222

2.8810

Ordinary share

Purchase

67

2.9515

Ordinary share

Purchase

1,532

2.8830

Ordinary share

Purchase

67

2.9795

Ordinary share

Purchase

1,639

2.8410

Ordinary share

Purchase

659

2.8450

Ordinary share

Purchase

1,963

2.9440

Ordinary share

Purchase

679

2.8810

Ordinary share

Purchase

1,332

2.8350

Ordinary share

Purchase

390

2.9940

Ordinary share

Purchase

16

2.9785

Ordinary share

Purchase

740

2.9900

Ordinary share

Purchase

200

2.9700

Ordinary share

Purchase

500

2.8930

Ordinary share

Purchase

677

2.9700

Ordinary share

Purchase

764

2.9880

Ordinary share

Purchase

811

2.8380

Ordinary share

Purchase

2,022

2.9440

Ordinary share

Purchase

2,163

2.8400

Ordinary share

Purchase

10

2.8150

Ordinary share

Purchase

352

2.9880

Ordinary share

Purchase

635

2.8840

Ordinary share

Purchase

777

2.9850

Ordinary share

Purchase

38

2.9510

Ordinary share

Purchase

63

2.9810

Ordinary share

Purchase

200

2.9300

Ordinary share

Purchase

2,194

2.8270

Ordinary share

Purchase

1,081

2.8440

Ordinary share

Purchase

500

2.9610

Ordinary share

Purchase

820

2.9420

Ordinary share

Purchase

1,077

2.9880

Ordinary share

Purchase

2,116

2.8270

Ordinary share

Purchase

340

2.9830

Ordinary share

Purchase

200

2.8830

Ordinary share

Purchase

677

2.9800

Ordinary share

Purchase

1,500

2.8370

Ordinary share

Purchase

400

2.8380

Ordinary share

Purchase

525

2.9900

Ordinary share

Purchase

1,013

2.8730

Ordinary share

Purchase

789

2.9900

Ordinary share

Purchase

67

2.9805

Ordinary share

Purchase

2,241

2.8640

Ordinary share

Purchase

637

2.9660

Ordinary share

Purchase

400

2.8380

Ordinary share

Purchase

360

2.9440

Ordinary share

Purchase

2,157

2.8640

Ordinary share

Purchase

497

2.8600

Ordinary share

Purchase

67

2.9510

Ordinary share

Purchase

323

2.8240

Ordinary share

Purchase

786

2.8350

Ordinary share

Purchase

2,145

2.8810

Ordinary share

Purchase

100

2.8270

Ordinary share

Purchase

11

2.9750

Ordinary share

Purchase

67

2.9510

Ordinary share

Purchase

100

2.9680

Ordinary share

Purchase

500

3.0150

Ordinary share

Purchase

67

2.9505

Ordinary share

Purchase

1,151

2.9830

Ordinary share

Purchase

472

2.9700

Ordinary share

Purchase

582

2.8860

Ordinary share

Purchase

1,073

2.8450

Ordinary share

Purchase

1,063

2.8900

Ordinary share

Purchase

634

2.8240

Ordinary share

Purchase

1,500

3.0090

Ordinary share

Purchase

550

2.9920

Ordinary share

Purchase

812

2.8140

Ordinary share

Purchase

620

2.8580

Ordinary share

Purchase

180

2.9570

Ordinary share

Purchase

67

2.9720

Ordinary share

Purchase

1

2.9780

Ordinary share

Purchase

395

2.9880

Ordinary share

Purchase

25

2.9900

Ordinary share

Purchase

2,095

2.8400

Ordinary share

Purchase

276

2.9920

Ordinary share

Purchase

963

2.9790

Ordinary share

Purchase

1,481

2.9830

Ordinary share

Purchase

223

2.9870

Ordinary share

Purchase

2,114

2.8640

Ordinary share

Purchase

66

2.9885

Ordinary share

Purchase

764

2.8230

Ordinary share

Purchase

2,266

2.8340

Ordinary share

Purchase

800

2.8350

Ordinary share

Purchase

78

2.9460

Ordinary share

Purchase

642

2.9860

Ordinary share

Purchase

614

2.8590

Ordinary share

Purchase

243

2.9670

Ordinary share

Purchase

2,170

2.8400

Ordinary share

Purchase

1,084

2.9900

Ordinary share

Purchase

1,148

2.9790

Ordinary share

Purchase

90

2.9440

Ordinary share

Purchase

67

2.9685

Ordinary share

Purchase

892

2.8350

Ordinary share

Purchase

972

2.9750

Ordinary share

Purchase

2,000

2.8150

Ordinary share

Purchase

263

2.9490

Ordinary share

Purchase

500

2.9610

Ordinary share

Purchase

67

2.9720

Ordinary share

Purchase

767

2.8900

Ordinary share

Purchase

2,141

2.8350

Ordinary share

Purchase

500

2.8730

Ordinary share

Purchase

1,599

2.9800

Ordinary share

Purchase

300

2.8520

Ordinary share

Purchase

585

2.9870

Ordinary share

Purchase

40

3.0090

Ordinary share

Purchase

2,099

2.8600

Ordinary share

Purchase

98

2.9780

Ordinary share

Purchase

637

2.8790

Ordinary share

Purchase

100

2.9300

Ordinary share

Purchase

132

2.9460

Ordinary share

Purchase

2,294

2.8480

Ordinary share

Purchase

2,194

2.8810

Ordinary share

Purchase

784

2.8360

Ordinary share

Purchase

773

2.9870

Ordinary share

Purchase

1,864

2.9440

Ordinary share

Purchase

954

2.9330

Ordinary share

Purchase

1,191

2.8730

Ordinary share

Purchase

67

2.9685

Ordinary share

Purchase

69

2.8590

Ordinary share

Purchase

70

2.8570

Ordinary share

Sale

1,711

2.8730

Ordinary share

Sale

2,669

2.8860

Ordinary share

Sale

200

2.8250

Ordinary share

Sale

1,804

2.8890

Ordinary share

Sale

67

2.9720

Ordinary share

Sale

7

2.9780

Ordinary share

Sale

2,067

2.8440

Ordinary share

Sale

67

2.9685

Ordinary share

Sale

7

2.9780

Ordinary share

Sale

100

2.8380

Ordinary share

Sale

1,265

2.8720

Ordinary share

Sale

540

2.8840

Ordinary share

Sale

67

2.9795

Ordinary share

Sale

2,095

2.8290

Ordinary share

Sale

300

2.8890

Ordinary share

Sale

2,209

2.9490

Ordinary share

Sale

8

2.9780

Ordinary share

Sale

391

2.8730

Ordinary share

Sale

300

2.8890

Ordinary share

Sale

41

2.9780

Ordinary share

Sale

1,201

2.9720

Ordinary share

Sale

1,083

2.9780

Ordinary share

Sale

70

2.8570

Ordinary share

Sale

1,882

2.8440

Ordinary share

Sale

1,918

2.9490

Ordinary share

Sale

67

2.9685

Ordinary share

Sale

7

2.9780

Ordinary share

Sale

63

2.9810

Ordinary share

Sale

66

2.9885

Ordinary share

Sale

7

2.9780

Ordinary share

Sale

2,134

2.8450

Ordinary share

Sale

2,140

2.8280

Ordinary share

Sale

1,004

2.8320

Ordinary share

Sale

841

2.8390

Ordinary share

Sale

100

2.8280

Ordinary share

Sale

454

2.8330

Ordinary share

Sale

429

2.8550

Ordinary share

Sale

300

2.9880

Ordinary share

Sale

1,680

2.8290

Ordinary share

Sale

7

2.9780

Ordinary share

Sale

8

2.9780

Ordinary share

Sale

2,144

2.8280

Ordinary share

Sale

285

2.8440

Ordinary share

Sale

400

2.8830

Ordinary share

Sale

472

2.8290

Ordinary share

Sale

7

2.9780

Ordinary share

Sale

500

2.8320

Ordinary share

Sale

2,152

2.8440

Ordinary share

Sale

943

2.8700

Ordinary share

Sale

1,029

2.9720

Ordinary share

Sale

800

2.8320

Ordinary share

Sale

2,179

2.8280

Ordinary share

Sale

452

2.8890

Ordinary share

Sale

7

2.9780

Ordinary share

Sale

2,188

2.8450

Ordinary share

Sale

67

2.9720

Ordinary share

Sale

16

2.9785

Ordinary share

Sale

753

2.9720

Ordinary share

Sale

2,296

2.8290

Ordinary share

Sale

69

2.8590

Ordinary share

Sale

2,057

2.9490

Ordinary share

Sale

610

2.9260

Ordinary share

Sale

580

2.9070

Ordinary share

Sale

1,200

2.8720

Ordinary share

Sale

1,876

2.8250

Ordinary share

Sale

821

2.8520

Ordinary share

Sale

600

2.9780

Ordinary share

Sale

67

2.9805

Total purchases

107,973

Total sales

55,946

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit (GBP)

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 

 

Date of disclosure:

14/06/2013

Contact name:

Benoît Champion

Telephone number:

+44 20 7676 6280

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

Identity of person whose open positions are being disclosed:

SOCIETE GENERALE SA

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

KAZAKHMYS PLC

 

2. OPTIONS AND DERIVATIVES

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Ordinary share

OTC put option

Sale

17 809

8,43

European options

13/10/2015

Ordinary share

OTC put option

Purchase

17 809

8,43

European options

13/10/2015

 

3. AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to contracts for differences ("CFDs") or spread bets.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOLIFVTRTISLIV

Related Shares:

KAZ.L
FTSE 100 Latest
Value8,417.34
Change2.09